s
Shivaya

For research sites and site networks

Your coordinators can't call every lead.
Maya can.

Shivaya finds, pre-screens, and warm-transfers trial-ready patients to your site — in minutes, not weeks. Our AI voice coordinator calls every qualified lead seconds after they raise their hand, runs your protocol's eligibility questions in a natural conversation, and hands you a patient who's ready to book.

The demo is Maya live, on your phone, in under two minutes.

Speed-to-lead is the whole game

Referrals go cold in minutes, a single patient review can consume nearly two hours of coordinator time, and pre-screening labor is the line item nobody funds. That's the gap Shivaya closes.

Seconds

from web pre-screen to Maya's call — 24/7, weekends included

100%

of qualified leads called, screened against your protocol, and documented

Warm transfer

eligible, motivated patients connected live to your front desk

How it works

1

Targeted outreach

IRB-approved digital ads reach patients near your site.

2

2-minute pre-screen

Protocol I/E criteria encoded as an instant web screener.

3

Maya calls in seconds

Natural-voice eligibility conversation with structured, auditable outcomes.

4

Warm transfer

Eligible patients connected live to your team, or booked for a screening visit.

Screening live today

Full funnels — landing pages, encoded eligibility criteria, and voice screening — are already built for these enrolling studies. If your site runs one of them, a pilot can start this week.

Type 2 Diabetes · Phase 2

Early Type 2 Diabetes Research Study

A Phase 2 clinical research study evaluating an investigational treatment for adults diagnosed with type 2 diabetes within the past 5 years who manage it with metformin or with diet and exercise alone.

NCT07546929 on ClinicalTrials.gov

Parkinson's Disease · Phase 2/3

Early Parkinson's Disease Research Study

A Phase 2/3 clinical research study evaluating an investigational once-daily treatment for adults recently diagnosed with Parkinson's disease who have not yet started Parkinson's medication.

NCT06976268 on ClinicalTrials.gov

Running a different study? We encode a new protocol — screener and voice script — in days, not months. 608 US research sites are already mapped in our routing graph.

Built compliance-first

TCPA consent, provable

Express written consent captured before any call — exact consent text, version, and timestamp stored on every lead. Maya discloses she's an AI and that calls are recorded, before any screening question.

PHI minimization

We collect only what screening requires. Site-scoped access controls mean your team sees your patients — nobody else's. BAAs executed for pilots.

IRB-ready materials

Ad creative, landing pages, and Maya's screening scripts are versioned and packaged for IRB submission per protocol. Nothing patient-facing runs without approval.

Pay for outcomes, not promises

Pilots are priced per qualified, screened referral — with a success component tied to randomization, so our incentives are yours. No platform fees until Shivaya is earning its keep across your studies.

Or request a pilot and we'll respond within one business day.